These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10816117)

  • 1. The molecular basis of lysosomal storage diseases and their treatment.
    Winchester B; Vellodi A; Young E
    Biochem Soc Trans; 2000 Feb; 28(2):150-4. PubMed ID: 10816117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal storage diseases: mechanisms of enzyme replacement therapy.
    Bou-Gharios G; Abraham D; Olsen I
    Histochem J; 1993 Sep; 25(9):593-605. PubMed ID: 8226100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.
    Jakóbkiewicz-Banecka J; Wegrzyn A; Wegrzyn G
    J Appl Genet; 2007; 48(4):383-8. PubMed ID: 17998597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for lysosomal storage diseases (LSDs) in large animal models.
    Haskins M
    ILAR J; 2009; 50(2):112-21. PubMed ID: 19293456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
    Jeyakumar M; Butters TD; Dwek RA; Platt FM
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):343-57. PubMed ID: 12366816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifying lysosomal storage diseases.
    Schultz ML; Tecedor L; Chang M; Davidson BL
    Trends Neurosci; 2011 Aug; 34(8):401-10. PubMed ID: 21723623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of gene therapy in canine and feline models of lysosomal storage disorders.
    Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders.
    Lachmann RH
    Drugs Today (Barc); 2006 Jan; 42(1):29-38. PubMed ID: 16511609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Genetics and Gene Therapy of Lysosomial Storage Disorders.
    Tuttolomondo A
    Curr Gene Ther; 2018; 18(2):66-67. PubMed ID: 29741137
    [No Abstract]   [Full Text] [Related]  

  • 12. Are there useful biochemical markers of disease activity in lysosomal storage diseases?
    Winchester B
    J Inherit Metab Dis; 2001; 24 Suppl 2():52-6; discussion 45-6. PubMed ID: 11758679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for Lysosomal Storage Disorders.
    Sheth J; Nair A
    Curr Pharm Des; 2020; 26(40):5110-5118. PubMed ID: 33059565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal storage diseases.
    Platt FM; d'Azzo A; Davidson BL; Neufeld EF; Tifft CJ
    Nat Rev Dis Primers; 2018 Oct; 4(1):27. PubMed ID: 30275469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of lysosomal storage disorders.
    Salvetti A; Heard JM; Danos O
    Br Med Bull; 1995 Jan; 51(1):106-22. PubMed ID: 7767637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current therapeutic strategies in lysosomal disorders].
    Kaminsky P; Lidove O
    Presse Med; 2014 Nov; 43(11):1174-84. PubMed ID: 24863660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on treatment of lysosomal storage diseases.
    Bruni S; Loschi L; Incerti C; Gabrielli O; Coppa GV
    Acta Myol; 2007 Jul; 26(1):87-92. PubMed ID: 17915580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.